Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole (Q53968585)
scientific article
Language:
Current Data About Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole
(P31) (Q13442814)
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

(P304) 332-341
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

(P407) (Q1860)

(P433) 3
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

(P478) 63
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

(P577) Sunday, March 1, 1998
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

(P921) (Q670131)
(P887)

(P1433) (Q1101529)
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

(P1476) "Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole" (language: en)
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

(P2093) Neuvonen PJ
(P1545) 1
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

Kantola T
(P1545) 2
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

Kivistö KT
(P1545) 3
(P248)
(P698) 9542477
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/9542477

(P2860) (Q43222775)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Sunday, January 21, 2018

(Q29547887)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q42664250)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q71965502)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q71778873)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q71658887)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q71214682)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q36851934)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q68026955)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q41348490)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q72728168)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q70557169)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q69241693)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q68171758)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q68077172)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q28236591)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q70687970)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q67566030)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

(Q71340074)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990165-5
(P813) Thursday, January 7, 2021

other details